Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Sep 4, 2020
Date Accepted: Mar 11, 2021

The final, peer-reviewed published version of this preprint can be found here:

Effects of Telemedicine and mHealth on Systolic Blood Pressure Management in Stroke Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Lv M, Wu T, Jiang S, Chen W, Zhang J

Effects of Telemedicine and mHealth on Systolic Blood Pressure Management in Stroke Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials

JMIR Mhealth Uhealth 2021;9(6):e24116

DOI: 10.2196/24116

PMID: 34114961

PMCID: 8235282

Effects of telemedicine and mobile health on systolic blood pressure management in stroke patients: a systematic review and meta-analysis of randomized controlled trials

  • Meina Lv; 
  • Tingting Wu; 
  • Shaojun Jiang; 
  • Wenjun Chen; 
  • Jinhua Zhang

ABSTRACT

Background:

Stroke is a common harmful disease with high recurrence and mortality rates. It not only affects patients’ quality of life, but also imposes a heavy economic burden on the family, medical system, and society. Uncontrolled blood pressure is an important and changeable risk factor for stroke recurrence. Mobile health (mhealth) interventions may have the potential to facilitate the control of blood pressure among stroke patients, but its effectiveness has not been established.

Objective:

This systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to estimate the effects of mhealth interventions on the control of systolic blood pressure among stroke patients, in order to provide a reference for clinical applications.

Methods:

The Cochrane evaluation method was adopted to conduct the systematic review. The research literature published up to June 2020 and consisting of RCTs related to mhealth interventions was searched in PubMed, EMBASE, Web of Science, and the Cochrane Library. The Cochrane Collaboration Risk of Bias Tool was used to evaluate the quality of the studies selected for the meta-analysis. A randomized or fixed-effects model was used to analyze changes in systolic blood pressure between the mhealth intervention group and the usual care group in the RCTs. The I2 statistic was used to assess heterogeneity.

Results:

Ten RCTs with a total sample size of 12974 stroke patients met the inclusion criteria. Compared with the usual care group, the mhealth intervention group had a significantly greater impact on the control of systolic blood pressure (mean difference (MD) -4.26 mmHg, 95% confidence interval (CI) -7.39 to -1.12; P=0.008). A subgroup analysis showed the intervention mode of telephone calls plus short message service (SMS) (MD -9.09 mmHg, 95% CI 12.71 to -5.46, P<0.001) or SMS reminder (MD -4.34 mmHg, 95% CI -6.55 to -2.13, P=0.0001), had a greater impact on the control of systolic blood pressure in the mhealth intervention group than the usual care group. Among the stroke patients with a baseline systolic blood pressure ≥140 mmHg (MD -6.15 mmHg, 95% CI -9.44 to -2.86: P=0.0002), or an intervention interval ≤1 week (MD -6.51, 95% CI -9.36 to -3.66: P<0.0001), the control of systolic blood pressure of the mhealth intervention group was better than that of the usual care group.

Conclusions:

In general, the mhealth interventions reduced the systolic blood pressure of the stroke patients by an average of 4.26 mmHg compared with usual care. Mhealth interventions are a relatively new intervention mode with potential applications for the control of systolic blood pressure among stroke patients, especially those with hypertensive stroke.


 Citation

Please cite as:

Lv M, Wu T, Jiang S, Chen W, Zhang J

Effects of Telemedicine and mHealth on Systolic Blood Pressure Management in Stroke Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials

JMIR Mhealth Uhealth 2021;9(6):e24116

DOI: 10.2196/24116

PMID: 34114961

PMCID: 8235282

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.